FDA Inspection 1140002 — Jeffrey S. Dome, M.D.

Jeffrey S. Dome, M.D. — FEI 3017810939

The FDA completed an inspection of Jeffrey S. Dome, M.D. on April 12, 2021 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 12, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Washington, DC (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
737821 CFR 50.27(a)Copy of consent form not provided
752021 CFR 312.64(b)Safety reports